Sarcopenia and Visceral Adiposity Did Not Affect Efficacy of Immune-Checkpoint Inhibitor Monotherapy for Pretreated Patients With Advanced Non-Small Cell Lung Cancer

BACKGROUND: This study aimed to investigate the association of computed tomography (CT)-assessed sarcopenia and visceral adiposity with efficacy and prognosis of immune-checkpoint inhibitor (ICI) therapy for pretreated non-small cell lung cancer (NSCLC). METHODS: We retrospectively collected 74 pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Minami, Seigo, Ihara, Shouichi, Tanaka, Tsunehiro, Komuta, Kiyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011908/
https://www.ncbi.nlm.nih.gov/pubmed/32095185
http://dx.doi.org/10.14740/wjon1225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011908/
https://www.ncbi.nlm.nih.gov/pubmed/32095185
http://dx.doi.org/10.14740/wjon1225

Ejemplares similares